Lidocaine Bp B. Braun Melsungen Ag

Lidocaine, the active ingredient in Lidocaine Bp B. Braun Melsungen Ag, is a local anesthetic presented as a sterile injectable solution for intradermal, intramuscular, and intravenous use. It provides temporary loss of sensation for minor surgical, dental, and pain‑management procedures. GNH USA supplies Lidocaine Bp B. Braun Melsungen Ag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic used to block nerve conduction in various procedural settings.

Minor surgical procedures: provides rapid, reversible loss of sensation to enable painless incision and excision. Dental procedures: numbs oral tissues to facilitate restorative, extraction or periodontal work. Pain management: offers temporary relief of localized postoperative or procedural pain.

Adverse reactions may occur following administration of lidocaine.

Common Side Effects: - Injection site pain or burning sensation. - Redness or mild swelling at the injection site. - Tingling or numbness that persists briefly after the procedure. - Light‑headedness or dizziness. - Nausea. - Metallic taste.

Serious or Rare Side Effects: - Systemic toxicity presenting as seizures, confusion or respiratory depression. - Cardiac arrhythmias, including bradycardia or ventricular tachycardia. - Severe hypotension. - Allergic reactions such as urticaria, angioedema or anaphylaxis. - Methemoglobinemia (rare).

Before using lidocaine, consider the following safety measures.

Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. Dose calculation: ensure appropriate dose based on patient weight, site and route. Cardiovascular monitoring: observe for signs of toxicity during and after administration. Concurrent CNS depressants: use with caution when combined with other central nervous system depressants. Pregnancy and lactation: weigh potential benefits against limited safety data. Store at room temperature: keep in original container, protect from light and moisture.

Lidocaine may interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): increase risk of cardiac toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise plasma lidocaine concentrations. - Beta‑adrenergic blockers: may potentiate cardiac depressant effects.

Moderate Interactions (Monitor Closely): - Class II antiarrhythmics (e.g., propranolol): may affect heart rate and rhythm. - Other local anesthetics: cumulative toxicity risk when used together. - General anesthetics (e.g., propofol, volatile agents): may enhance central nervous system depression.